ArrowArtboardCreated with Sketch.Title ChevronCrossEye IconFacebook IconIcon FacebookGoogle Plus IconLayer 1InstagramCreated with Sketch.Linkedin IconIcon LinkedinShapeCreated with Sketch.Icon Mail ContactPath LayerIcon MailMenu BurgerIcon Opinion QuotePositive ArrowIcon PrintRSS IconIcon SearchSite TitleTitle ChevronTwitter IconIcon TwitterYoutube Icon
Health Services

IHH Healthcare Bhd.

  • 5.96 MYR
  • -0.07
  • -1.16%
  • Malaysia
    Jul 18, 2018
  • Ticker
    KLS(5225)
  • Prev. close
    6.03
  • Market cap (MYR)
    49,715.80M
  • Market cap (USD)
    12,248.27M
  • Shares
    8,244.74M

Company Background

IHH Healthcare runs 37 private hospitals in 10 countries, including China and India. Its facilities have a total of more than 6,000 beds.

Headquartered in Malaysia, the company also sees Singapore and Turkey as its home markets. Its hospitals in these three countries attract affluent patients from across Southeast Asia and the Middle East. The group's Mount Elizabeth and Gleneagles hospitals in Singapore are considered particularly prestigious, thanks to their state-of-the-art medical equipment.

IHH is 44% owned by Khazanah Nasional, an investment arm of the Malaysian government. Khazanah in 2010 defeated a rival bid from India's Fortis Healthcare to take control of Parkway Holdings, a then-listed Singaporean company, which owned hospitals in Malaysia and Singapore. Today, Parkway is a wholly owned IHH subsidiary.

IHH is listed in both Malaysia and Singapore. The group is led by CEO Tan See Leng, who is also a doctor. Tan joined Parkway in 2004 and held various high-ranking positions before the company slid under IHH's umbrella.

Globally, IHH is the second-largest health care operator by market capitalization. Japanese trading house Mitsui & Co. is a major shareholder.

Business Summary

IHH Healthcare Bhd. is an investment holding company, which engages in the provision of healthcare services. It operates through the following segments: Parkway Pantai, PPL Others, CEEMENA, and Others. The Parkway Pantai segment comprises the Parkway Pantai and PLife REIT. The PPL Others segment includes Pantai's hospital in Brunei, and corporate office as well as other investment holding entities within Parkway Pantai. The CEEMENA segment refers to Central and Eastern Europe, Middle East, and North Africa. The company was founded on May 21, 2010 and is headquartered in Kuala Lumpur, Malaysia.

Financial Highlights

Dec 2017 MYRUSD
Revenue11,142.63M2,591.60M
Gross Profit2,621.66M609.75M
Operating income1,214.57M282.49M
Income before tax1,162.33M270.34M
Net income931.31M216.60M
EBITDA2,191.18M509.63M
Diluted EPS0.110.02
Dividends Per Share0.030.00
Total Assets38,941.01M9,622.19M
Total liabilities15,198.95M3,755.60M
Total equity21,890.16M5,408.98M
Operating cash flow2,006.03M466.57M
Currency in MYRCurrency in USD

Historical Data

 Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017
Revenue 6,756.45M 7,344.01M 8,455.46M 10,021.88M 11,142.63M
Gross Profit 1,762.67M 2,020.36M 2,327.18M 2,657.91M 2,621.66M
Operating income 926.70M 1,074.16M 1,210.55M 1,227.74M 1,214.57M
Income before tax 879.38M 1,211.32M 1,203.25M 860.94M 1,162.33M
Net income 631.15M 754.29M 933.90M 612.35M 931.31M
EBITDA 1,527.56M 1,682.34M 1,900.05M 2,026.87M 2,191.18M
Diluted EPS 0.07 0.09 0.11 0.07 0.11
Dividends Per Share 0.02 0.03 0.03 0.03 0.03
Total Assets 27,261.54M 28,680.13M 35,517.48M 37,200.39M 38,941.01M
Total liabilities 7,338.60M 7,366.73M 11,280.78M 13,307.23M 15,198.95M
Total equity 18,075.14M 19,451.74M 22,155.73M 21,985.74M 21,890.16M
Operating cash flow 1,241.46M 1,557.92M 1,863.97M 1,730.45M 2,006.03M
 Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017
Revenue 2,144.57M 2,244.48M 2,162.70M 2,419.15M 2,591.60M
Gross Profit 559.49M 617.46M 595.23M 641.58M 609.75M
Operating income 294.14M 328.28M 309.63M 296.36M 282.49M
Income before tax 279.12M 370.20M 307.76M 207.82M 270.34M
Net income 200.33M 230.52M 238.86M 147.81M 216.60M
EBITDA 484.86M 514.16M 485.98M 489.26M 509.63M
Diluted EPS 0.02 0.02 0.02 0.01 0.02
Dividends Per Share 0.00 0.00 0.00 0.00 0.00
Total Assets 8,322.86M 8,202.52M 8,272.38M 8,292.55M 9,622.19M
Total liabilities 2,240.45M 2,106.88M 2,627.40M 2,966.39M 3,755.60M
Total equity 5,518.28M 5,563.20M 5,160.29M 4,900.96M 5,408.98M
Operating cash flow 394.05M 476.13M 476.75M 417.70M 466.57M

Valuation Measures

Dec 2017
PER51.81
ROA2.44%
ROE4.24%
Operating margin10.90%
Profit margin8.35%

Key executives

  • CEO, MD & Non-Independent Executive Director: See Leng Tan
  • Group Chief Operating Officer: Suet Wun Lim
  • Group Chief Financial Officer: Soon Teck Low
  • Group Head-Internal Audit: Audrey Huang
  • Assistant Vice President-Investor Relations: Penelope Koh

Shareholders

  • Khazanah Nasional Bhd. (Investment Company) (40.4%)
  • Mitsui & Co., Ltd. (18.0%)
  • Employees Provident Fund (8.7%)
  • Singapore Exchange Ltd. (5.0%)
  • Permodalan Nasional Bhd. (3.8%)
  • AYDINLAR MEHMET ALI (2.1%)
  • Public Mutual Bhd. (1.9%)
  • Kuwait Investment Authority (Investment Management) (1.7%)
  • Kumpulan Wang Persaraan (1.6%)
  • GIC Pte Ltd. (Investment Management) (1.5%)

Contact Details

  • Website:http://www.ihh-healthcare.com
  • Address: Level 11 Block A, Pantai Hospital, Kuala Lumpur, 8 Jalan Bukit Pantai, Kuala Lumpur, 59100, Malaysia
  • Phone: +60.3.2298.9898

Related Companies

  • Northern TK Venture Pte Ltd.
  • IHH Healthcare Bhd. (Singapore)
  • Indah Capital Ltd.
  • Shanghai Mai Kang Hospital Investment Management Co. Ltd.
  • Bodrum Tedavi Hizmetleri A.S
  • Integrated Healthcare Turkey Yatirimlari Ltd.
  • Gleneagles Development Pte Ltd.
  • Integrated Healthcare Holdings Ltd.
  • Parkway Holdings Ltd.

Competitors

    Last Updated on 18 Jul, 2018

    You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

    Subscribe to get unlimited access to all articles.

    Get unlimited access
    NAR site on phone, device, tablet

    You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month

    Subscribe to get unlimited access to all articles.

    3 months for $9

    Get unlimited access
    NAR site on phone, device, tablet

    Your trial period has expired

    You need a subscription to...

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers and subscribe

    Your full access to the Nikkei Asian Review has expired

    You need a subscription to:

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers
    NAR on print phone, device, and tablet media